Task Force: Recipients Of Second Dose Of COVID-19 Vaccine Achieved 171.06 Million People

Illustration. (Photo: Doc. Antara)

JAKARTA - The COVID-19 Handling Task Force (Satgas) said the recipient of the second dose of the COVID-19 vaccine had reached 171,064,873 after an increase of 4,162 people until 12.00 WIB. In data from the Task Force in Jakarta, Saturday, September 3, it was stated that the increase also occurred in the coverage of the first dose, which now increased by 7,632 people. So the total nationally reached 203,397,204 people. Then the recipients of the third dose have reached 60,912,034 people, after adding 12,664 people. While the fourth dose, which is now only prioritized for health workers (nakes), has reached 380,726 people. It increased by 3,036 from the previous day. The government itself is now targeting 234,666,020 as the target of the spread of the COVID-19 vaccine in Indonesia. Previously, Professor of the Department of Microbiology, Faculty of Medicine, University of Indonesia (FKUI) Prof Amin Soebandrio, stated that the mutation had caused new variants of COVID-19 to weaken. The mutation actually makes the virus appear weak. Only four to five percent of the mutation can make the virus fit or adapt, ” Amin said, quoted by. He said if the mutation of the virus could occur randomly. In that process, the virus will replicate to increase itself when finding new people (hosts) to be transmitted, but there is a possibility if there is a misappropriation of genetic material. As a result, only four to five percent of viruses from mutation results can adapt to the environmental pressure in the vicinity, either due to drugs or antibodies. This opportunity must then be faced by Indonesia. This condition cannot be underestimated because it causes the risk of transmission to occur on any party. He emphasized that the vaccine that has been obtained by the community regardless of the number of doses, can be very useful and form immunity in the community. Vaccination provides protection from viruses that continue to mutate and continue to change. Several large vaccine companies are also working to adapt their vaccines to the new variant of the variant. He hopes that vaccination coverage can continue to be increased without having to be inequality in each group in society. <quo;Speaking of mutations as long as we can prevent the virus from finding new hosts (via vaccinations), it will minimize the possibility of the virus mutating, that's what we have to do, ” said Amin Soebandrio.